Yacoub, A., Odenike, O., & Verstovsek, S. (2014). Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms. Curr Hematol Malig Rep.
Styl ChicagoYacoub, A., O. Odenike, a S. Verstovsek. "Ruxolitinib: Long-Term Management of Patients With Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms." Curr Hematol Malig Rep 2014.
Citace podle MLAYacoub, A., O. Odenike, a S. Verstovsek. "Ruxolitinib: Long-Term Management of Patients With Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms." Curr Hematol Malig Rep 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..